PTC
RPRX icon

Petrus Trust Company’s Royalty Pharma RPRX Stock Holding History

Petrus Trust Company’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,287
Closed -$227K – 688
2025
Q1 		$227K Buy
+7,287
New +$231K 0.02% 497
2024
Q1 		– Sell
-13,701
Closed -$385K – 764
2023
Q4 		$385K Sell
13,701
-4,013
-23% -$110K 0.04% 335
2023
Q3 		$481K Hold
17,714
– – 0.05% 194
2023
Q2 		$545K Buy
17,714
+10,537
+147% +$357K 0.06% 125
2023
Q1 		$259K Hold
7,177
– – 0.03% 373
2022
Q4 		$284K Buy
+7,177
New +$300K 0.04% 290

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CIA
Caledonia Investments (Australia) Sydney NSW, Australia $3.44B AUM 20.03% 1-Year Est. Return